News

Both the companies entered into the collaboration in December 2010 under which Phylogica has identified various peptides from its Phylomer libraries that will be further evaluated for their

Gilenya, licensed from Mitsubishi Tanabe Pharma is the first in a new class of compounds called sphingosine 1-phosphate receptor (S1PR) modulators. The two-year placebo-controlled parallel-group multi-centre Phase III

Shape memory polymers are made of advanced materials which can remember more many shapes and can transit easily between those shapes with minimal force and without loss of

CaveGrouper-Lite groups over 15,000 ICD-9 and 68,000 ICD-10 diagnosis codes into meaningful medical conditions that account for 100% of all medical conditions and expenditures. The software builds longitudinal

Salix has a license to the HIV-associated diarrhea indication for Crofelemer and the additional indications of pediatric diarrhea and acute infectious diarrhea in North America, Europe and Japan.

The capsules are rich in antioxidants and probiotics for digestive health from over 20 different vitamins and minerals, and can either be swallowed as pills or opened and

The company claims that energy bar utilises the highest quality 100% natural, organic ingredients that are Organic and Kosher certified ingredients. Active X energy bars is available in

MMRF’s Personalized Medicine Initiative has been developed to allow molecular characterization of multiple myeloma patients and thus enforce the development of new, targeted treatments. Onyx is believed to

Under the contract, SRI will carry on with the development of NIAID’s Division of Microbiology and Infectious Diseases (DMID) program that involves translation of basic research into clinical